The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires

Radiotherapy and Oncology

Volumn 78, Issue 3, 2006, Pages 298-305

  Jensen, Kenneth ^a   Bonde Jensen, Anders ^a   Grau, Cai ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Adverse events; Head and neck neoplasm; Morbidity; Quality of life; Radiotherapy; Side effects; Surgery; Toxicity

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL OBSERVATION; CORRELATION ANALYSIS; DANISH HEAD AND NECK CANCER TOXICITY SCORING SYSTEM; DISEASE SEVERITY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEAD AND NECK CANCER; HUMAN; INTERMETHOD COMPARISON; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PATIENT ASSESSMENT; PHARYNX CANCER; PHYSICIAN; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RECORDING; SCORING SYSTEM; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOM; TOXICITY;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; STATISTICS; TREATMENT OUTCOME;

EID: 33645959171     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.02.005     Document Type: Article

References (31)

1. Dische S., Warburton M.F., Jones D., and Lartigau E. The recording of morbidity related to radiotherapy. Radiother Oncol 16 (1989) 103-108
2. Miller A.B., Hoogstraten B., Staquet M., and Winkler A. Reporting results of cancer treatment. Cancer 47 (1981) 207-214
3. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
4. Pavy J.J., Denekamp J., Letschert J., et al. EORTC late effects working group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol 35 (1995) 11-15
5. Rubin P., Constine III L.S., Fajardo L.F., Phillips T.L., and Wasserman T.H. EORTC late effects working group. Overview of late effects normal tissues (LENT) scoring system. Radiother Oncol 35 (1995) 9-10
6. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003) 176-181
7. Overgaard J., Hansen H.S., Specht L., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362 (2003) 933-940
8. Dische S. The uniform reporting of treatment-related morbidity. Semin Radiat Oncol 4 (1994) 112-118
9. Hjelm-Hansen M., Jorgensen K., Andersen A.P., and Lund C. Laryngeal carcinoma. II. Analysis of treatment results using the Ellis model. Acta Radiol Oncol Radiat Phys Biol 18 (1979) 385-407
10. Bjordal K., Hammerlid E., Ahlner-Elmqvist M., et al. Quality of life in head and neck cancer patients: validation of the European organization for research and treatment of cancer quality of life questionnaire-H&N35. J Clin Oncol 17 (1999) 1008-1019
11. Bjordal K., de Graeff A., Fayers P.M., et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer 36 (2000) 1796-1807
12. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
13. Bjordal K., Kaasa S., and Mastekaasa A. Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys 28 (1994) 847-856
14. Jensen K, Bonde JA, Grau C. A cross sectional quality of life study of 116 recurrence free head and neck cancer patients. The first use of EORTC H&N35 in Danish. Acta Oncol 2006;45:28-37.
15. Fang F.M., Liu Y.T., Tang Y., Wang C.J., and Ko S.F. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer 100 (2004) 425-432
16. de Graeff A., de Leeuw J.R., Ros W.J., Hordijk G.J., Blijham G.H., and Winnubst J.A. Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer 37 (2001) 332-339
17. Montazeri A., Milroy R., Hole D., McEwen J., and Gillis C.R. Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer 31 (2001) 233-240
18. de Graeff A., de Leeuw J.R., Ros W.J., Hordijk G.J., Blijham G.H., and Winnubst J.A. Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck 22 (2000) 398-407
19. Sherman A.C., Simonton S., Adams D.C., Vural E., Owens B., and Hanna E. Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) quality of life head and neck module (QLQ-H&N35). Arch Otolaryngol Head Neck Surg 126 (2000) 459-467
20. Ringash J., Redelmeier D.A., O'Sullivan B., and Bezjak A. Quality of life and utility in irradiated laryngeal cancer patients. Int J Radiat Oncol Biol Phys 47 (2000) 875-881
21. Pignon T., Horiot J.C., Van den B.W., Van Glabbeke M., and Scalliet P. No age limit for radical radiotherapy in head and neck tumours. Eur J Cancer 32A (1996) 2075-2081
22. Huguenin P., Glanzmann C., and Lutolf U.M. Acute toxicity of curative radiotherapy in elderly patients. Strahlenther Onkol 172 (1996) 658-663
23. Schofield C.P., Sykes A.J., Slevin N.J., and Rashid N.Z. Radiotherapy for head and neck cancer in elderly patients. Radiother Oncol 69 (2003) 37-42
24. Browman G.P., Levine M.N., Hodson D.I., et al. The head and neck radiotherapy questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. J Clin Oncol 11 (1993) 863-872
25. Klepstad P., Hilton P., Moen J., Fougner B., Borchgrevink P.C., and Kaasa S. Self-reports are not related to objective assessments of cognitive function and sedation in patients with cancer pain admitted to a palliative care unit. Palliat Med 16 (2002) 513-519
26. Movsas B., Scott C., Langer C., et al. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01. J Clin Oncol 23 (2005) 2145-2154
27. Stephens R.J., Hopwood P., Girling D.J., and Machin D. Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings?. Qual Life Res 6 (1997) 225-236
28. Eisbruch A., Lyden T., Bradford C.R., et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 53 (2002) 23-28
29. Pauloski B.R., Rademaker A.W., Logemann J.A., et al. Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck 24 (2002) 555-565
30. Logemann J.A., Smith C.H., Pauloski B.R., et al. Effects of xerostomia on perception and performance of swallow function. Head Neck 23 (2001) 317-321
31. Eisbruch A., Kim H.M., Terrell J.E., Marsh L.H., Dawson L.A., and Ship J.A. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 695-704